C.B. Fleet Tagged Articles

Lawsuits citing kidney injury from OsmoPrep commence

Posted: January 13, 2010 Pharmaceutical

Lawsuits began last month for four people who say the prescription bowel cleanser OsmoPrep caused them kidney damage that resulted in dialysis. OsmoPrep, made by Salix Pharmaceuticals, is a type of laxative called oral sodium phosphate, or OSP, used to

Take your health into your own hands; Don’t use OSP products

Posted: October 22, 2009 Pharmaceutical

One of the hottest topics in nephrology over the past few years has been the epidemiologic and histopathologic studies that suggest a link between oral sodium phosphate (OSP) colonoscopy preparations and a serious form of kidney injury known as acute

Virtual colonoscopy shows promising results

Posted: September 22, 2009 Pharmaceutical

A study by a group of Italian researchers shows that virtual colonoscopies that use computer tomography scans are almost as effective at detecting tumors and precancerous lesions as standard colonoscopies, which requires threading a camera through the colon. The study,

Lawsuits mount against maker of over-the-counter bowel cleanser

Posted: September 10, 2009 Pharmaceutical

The Food and Drug Administration (FDA) black box warning on oral sodium phosphates (OSPs) came late last year, but as early as 2003, doctors were beginning to make the link between OSP pills and solutions used to clear the bowel

Oprah, Oz sue colon cleanse company over false advertising

Posted: August 21, 2009 Pharmaceutical

Internet commercials for colon cleansing products featuring the images, names and voices of Oprah Winfrey and her friend Dr. Oz are a hoax, says Winfrey and Oz, and they have filed a lawsuit in New York Federal Court to take

Canada orders makers of common OTC laxatives to re-label

Posted: August 11, 2009 Pharmaceutical

Health Canada has ordered manufacturers of over-the-counter oral sodium phosphates (OSP), such as Fleet Phospho-Soda, to either re-label the products to remove any mention of bowel cleansing, or remove the products completely from the Canadian market.

Colorectal cancer rates rise among young adults

Posted: July 28, 2009 Pharmaceutical

While overall colorectal cancer rates are steadily decreasing, colorectal cancer rates among younger patients are on the rise, according to data collected from the 13 Surveillance, Epidemiology, and End Results (SEER) cancer registries nationwide and studied by the American Cancer Society.

OSP products ‘should not be prescribed at all’

Posted: July 16, 2009 Pharmaceutical

A 62-year-old woman preparing for a colonoscopy followed her doctor’s orders and took a large dose of an oral sodium phosphate (OSP) solution to cleanse her bowel before the procedure. It wasn’t an unusual order. Many physicians either prescribe OSP

Recalled over-the-counter OSP products still on shelves in Jamaica

Posted: July 15, 2009 Pharmaceutical

When the Food and Drug Administration (FDA) issued a black box warning on prescription oral sodium phosphates (OSP) Visicol and Osmo Prep, medications used to clear the bowel before colonoscopies and other procedures, C.B. Fleet also removed its over-the-counter OSP

Thousands could be injured each year by OSP bowel cleansers

Posted: July 10, 2009 Pharmaceutical

Two studies in the Journal of the American Society of Nephrology (JASN) suggest that at least 50 percent of patients undergoing a screening colonoscopy receive oral sodium phosphates (OSP) to prep their bowel. Which means as many as 7 million